Dermatology’s growing focus on skin longevity demands clear definitions, validated outcomes, and rigorous evidence beyond anti-aging claims.
|Articles|May 1, 2004
Urea vehicle promotes tolerability of topical acne medication
Washington, D.C. - A unique urea-containing vehicle appears to improve the tolerability of topical treatment with sodium sulfacetamide/sulfur in acne and rosacea patients with sensitive skin, according to the results of a randomized, double-blind, active comparator-controlled study presented by James J. Leyden, M.D., at the annual meeting of the American Academy of Dermatology.
Advertisement
Advertisement
Related to this article
Castor oil has become a popular social media remedy for thicker, longer hair, but evidence supporting its ability to stimulate hair growth remains limited.
Can “Botox in a bottle” really rival injectable neuromodulators? We examine the evidence behind topical peptide serums and Argireline.
Advertisement
Advertisement
Trending on Dermatology Times
1
AAD, HS Foundation Issue First Joint Hidradenitis Suppurativa Guidelines
2
Dupilumab Associated With Lower Atopic March Risk in Pediatric Atopic Dermatitis
3
Nonsteroidal Topicals Guide Special-Site Psoriasis Treatment Decisions
4
Lutikizumab Meets Primary End Point in Phase 3 HS Trial
5